Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.

The Korean journal of parasitology

Volumn 44, Issue 3, 2006, Pages 221-228

  Krudsood, Srivicha ^a   Wilairatana, Polrat ^a   Tangpukdee, Noppadon ^a   Chalermrut, Kobsiri ^a   Srivilairit, Siripun ^a   Thanachartwet, Vipa ^a   Muangnoicharoen, Sant ^a   Luplertlop, Natthanej ^a   Brittenham, Gary M ^a   Looareesuwan, Sornchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (3 ACETYL 4,5 DIHYDRO 2 FURYLAMINO) 1 METHYLBUTYLAMINO] 6 METHOXYQUINOLINE; ANTIMALARIAL AGENT; CHLOROQUINE; COMPOUND 80-53; DRUG DERIVATIVE; PRIMAQUINE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALARIA; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THAILAND;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; PROSPECTIVE STUDIES; THAILAND;

EID: 33750129303     PISSN: 00234001     EISSN: None     Source Type: Journal    
DOI: 10.3347/kjp.2006.44.3.221     Document Type: Article

References (0)